BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15581417)

  • 21. Potential of interferon-alpha in solid tumours: part 1.
    Decatris M; Santhanam S; O'Byrne K
    BioDrugs; 2002; 16(4):261-81. PubMed ID: 12196039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. STAT5 contributes to interferon resistance of melanoma cells.
    Wellbrock C; Weisser C; Hassel JC; Fischer P; Becker J; Vetter CS; Behrmann I; Kortylewski M; Heinrich PC; Schartl M
    Curr Biol; 2005 Sep; 15(18):1629-39. PubMed ID: 16169484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of 5-FU and IFNalpha enhances IFN signaling pathway and caspase-8 activity, resulting in marked apoptosis in hepatoma cell lines.
    Koike K; Takaki A; Tatsukawa M; Suzuki M; Shiraha H; Iwasaki Y; Sakaguchi K; Shiratori Y
    Int J Oncol; 2006 Nov; 29(5):1253-61. PubMed ID: 17016659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New pharmacokinetic and pharmacodynamic tools for interferon-alpha (IFN-alpha) treatment of human cancer.
    Tagliaferri P; Caraglia M; Budillon A; Marra M; Vitale G; Viscomi C; Masciari S; Tassone P; Abbruzzese A; Venuta S
    Cancer Immunol Immunother; 2005 Jan; 54(1):1-10. PubMed ID: 15693134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphoinositide 3-kinase regulates a subset of interferon-alpha-stimulated genes.
    Hjortsberg L; Lindvall C; Corcoran M; Arulampalam V; Chan D; Thyrell L; Nordenskjold M; Grandér D; Pokrovskaja K
    Exp Cell Res; 2007 Jan; 313(2):404-14. PubMed ID: 17141757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bovine serum amine oxidase and spm potentiate docetaxel and interferon-alpha effects in inducing apoptosis on human cancer cells through the generation of oxidative stress.
    Marra M; Lombardi A; Agostinelli E; Giuberti G; Zappavigna S; Tempera G; Vitale G; Bifulco M; Abbruzzese A; Caraglia M
    Biochim Biophys Acta; 2008 Dec; 1783(12):2269-78. PubMed ID: 18848847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon-gamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis C.
    Radaeva S; Jaruga B; Kim WH; Heller T; Liang TJ; Gao B
    Biochem J; 2004 Apr; 379(Pt 1):199-208. PubMed ID: 14690454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IFNalpha and IFNlambda differ in their antiproliferative effects and duration of JAK/STAT signaling activity.
    Maher SG; Sheikh F; Scarzello AJ; Romero-Weaver AL; Baker DP; Donnelly RP; Gamero AM
    Cancer Biol Ther; 2008 Jul; 7(7):1109-15. PubMed ID: 18698163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of interferon alpha-2b and beta on the signaling pathways in human liver cancer cells.
    Matsumoto K; Okano J; Murawaki Y
    J Gastroenterol; 2005 Jul; 40(7):722-32. PubMed ID: 16082589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferons alpha and gamma induce p53-dependent and p53-independent apoptosis, respectively.
    Porta C; Hadj-Slimane R; Nejmeddine M; Pampin M; Tovey MG; Espert L; Alvarez S; Chelbi-Alix MK
    Oncogene; 2005 Jan; 24(4):605-15. PubMed ID: 15580300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The RAS/Raf1/MEK/ERK signaling pathway facilitates VSV-mediated oncolysis: implication for the defective interferon response in cancer cells.
    Noser JA; Mael AA; Sakuma R; Ohmine S; Marcato P; Lee PW; Ikeda Y
    Mol Ther; 2007 Aug; 15(8):1531-6. PubMed ID: 17505473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blocking autophagy flux promotes interferon-alpha-mediated apoptosis in head and neck squamous cell carcinoma.
    Yang W; Jiang C; Xia W; Ju H; Jin S; Liu S; Zhang L; Ren G; Ma H; Ruan M; Hu J
    Cancer Lett; 2019 Jun; 451():34-47. PubMed ID: 30862487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study on the biological activity and molecular mechanism of IFNalpha on human myeloma cell line Sko-007].
    Song L; Li Y; Sun Y; Shen B
    Zhonghua Xue Ye Xue Za Zhi; 2002 Oct; 23(10):517-9. PubMed ID: 12482347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of interferon alfa signaling components in human alcoholic liver disease.
    Nguyen VA; Gao B
    Hepatology; 2002 Feb; 35(2):425-32. PubMed ID: 11826419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon-alpha induces TRAIL expression and cell death via an IRF-1-dependent mechanism in human bladder cancer cells.
    Papageorgiou A; Dinney CP; McConkey DJ
    Cancer Biol Ther; 2007 Jun; 6(6):872-9. PubMed ID: 17617740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon alpha2b increases paracellular permeability of renal proximal tubular LLC-PK1 cells via a mitogen activated protein kinase signaling pathway.
    Lechner J; Pfaller W
    Ren Fail; 2001; 23(3-4):573-88. PubMed ID: 11499571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defective Jak-STAT signal transduction pathway in melanoma cells resistant to growth inhibition by interferon-alpha.
    Pansky A; Hildebrand P; Fasler-Kan E; Baselgia L; Ketterer S; Beglinger C; Heim MH
    Int J Cancer; 2000 Mar; 85(5):720-5. PubMed ID: 10699955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intensified antineoplastic effect by combining an HDAC-inhibitor, an mTOR-inhibitor and low dosed interferon alpha in prostate cancer cells.
    Tsaur I; Hudak L; Makarević J; Juengel E; Mani J; Borgmann H; Gust KM; Schilling D; Bartsch G; Nelson K; Haferkamp A; Blaheta RA
    J Cell Mol Med; 2015 Aug; 19(8):1795-804. PubMed ID: 25808196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon Alpha Signalling and Its Relevance for the Upregulatory Effect of Transporter Proteins Associated with Antigen Processing (TAP) in Patients with Malignant Melanoma.
    Heise R; Amann PM; Ensslen S; Marquardt Y; Czaja K; Joussen S; Beer D; Abele R; Plewnia G; Tampé R; Merk HF; Hermanns HM; Baron JM
    PLoS One; 2016; 11(1):e0146325. PubMed ID: 26735690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The JAK/STAT pathway is not sufficient to sustain the antiproliferative response in an interferon-resistant human melanoma cell line.
    Jackson DP; Watling D; Rogers NC; Banks RE; Kerr IM; Selby PJ; Patel PM
    Melanoma Res; 2003 Jun; 13(3):219-29. PubMed ID: 12777975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.